Skip to main content

Prevalence and aetiologies of anaemia among first trimester pregnant women in Sri Lanka; the need for revisiting the current control strategies



The Sustainable development goals, which focus strongly on equity, aim to end all forms of malnutrition by 2030. However, a significant cause of intergenerational transfer of malnutrition, anaemia in pregnancy, is still a challenge. It is especially so in the low- and middle-income settings where possible context-specific aetiologies leading to anaemia have been poorly explored. This study explores the prevalence of etiological factors significantly contributing to anaemia in pregnancy in Sri Lanka, a lower-middle-income country with a high prevalence of malnutrition albeit robust public health infrastructure.


All first-trimester pregnant women registered in the public maternal care programme in the Anuradhapura district from July to September 2019 were invited to participate in Rajarata Pregnancy Cohort (RaPCo). After a full blood count analysis, high-performance liquid chromatography, peripheral blood film examination, serum B12 and folate levels were performed in anaemic participants, guided by an algorithm based on the red cell indices in the full blood count. In addition, serum ferritin was tested in a random subsample of 213 participants. Anaemic women in this subsample underwent B12 and folate testing.


Among 3127 participants, 14.4% (95%CI 13.2–15.7, n = 451) were anaemic. Haemoglobin ranged between 7.4 to 19.6 g/dl. 331(10.6%) had mild anaemia. Haemoglobin ≥13 g/dl was observed in 39(12.7%). Microcytic, normochromic-normocytic, hypochromic-normocytic and macrocytic anaemia was observed in 243(54%), 114(25.3%), 80(17.8%) and two (0.4%) of full blood counts in anaemic women, respectively. Microcytic anaemia with a red cell count ≥5 * 106 /μl demonstrated a 100% positive predictive value for minor haemoglobinopathies. Minor hemoglobinopathies were present in at least 23.3%(n = 105) of anaemic pregnant women. Prevalence of iron deficiency, B12 deficiency and Southeast Asian ovalocytosis among the anaemic was 41.9% (95%CI 26.4–59.2), 23.8% (95%CI 10.6–45.1) and 0.9% (95%CI 0.3–2.3%), respectively. Folate deficiency was not observed.


Even though iron deficiency remains the primary cause, minor hemoglobinopathies, B 12 deficiency and other aetiologies substantially contribute to anaemia in pregnancy in this study population. Public health interventions, including screening for minor hemoglobinopathies and multiple micronutrient supplementation in pregnancy, should be considered in the national programme for areas where these problems have been identified.

Peer Review reports


Anaemia in pregnancy is a major public health problem as many countries across the globe are struggling to quantify, prevent and treat this condition. The global prevalence of this issue is estimated to be around 38%, while 58.1% of South Asian pregnant women are thought to be anaemic [1]. The sustainable development goals call for ending all forms of malnutrition, including anaemia, by 2030, highlighting the need for mending the inequality gaps at global, national and subnational levels [2]. However, in low and middle-income countries (LMICs), slow and uneven progress in the prevention of anaemia is reported specifically due to complex context-specific aetiologies that are poorly identified [3].

Anaemia during pregnancy can adversely affect both the mother and the foetus. Severely anaemic pregnant women have a 2.36 times higher risk of death than other pregnant women [4] and are more vulnerable to adverse pregnancy outcomes [5]. Maternal anaemia also increases the baby’s risk for intellectual development problems, obesity, cardiac diseases and anaemia [6,7,8,9].

Traditionally the most typical cause of anaemia is iron deficiency, contributing to more than 50% of anaemia in pregnancy worldwide [10, 11]. The demand for iron is increased during pregnancy due to increased maternal erythropoiesis. Iron is also required for the growth of foetal tissues and iron stores [12,13,14]. When the supply fails to meet the increased demand due to various reasons such as poor diet, infections or infestations, iron stores in the body gradually depletes, manifesting as iron deficiency anaemia at some point. In addition to anaemia, iron deficiency can lead to maternal fatigue and hormonal derangements, and increase the risk of postpartum haemorrhage and depression [15,16,17,18]. It can also lead to iron deficiency in the offspring, especially when it is present during late pregnancy [19].

Other micronutrient deficiencies (like Folate, Vitamin B12, vitamin B6, vitamin A, vitamin C and Zinc), hemoglobinopathies, red cell membrane disorders, and systemic causes (such as hormonal disorders, liver diseases, malaria and Human Immunodeficiency Virus (HIV)) also contribute to anaemia in pregnancy [20, 21]. The contribution of each of these aetiologies to anaemia among pregnant women will vary in different communities. How different etiological factors would affect the mother’s overall health, and the baby is also diverse.

As an example, folate deficiency is high in malaria-endemic regions and in countries where the staple food is not fortified with folate [3]. Pregnant women are specially vulnerable to folate deficiency as its requirement is significantly increased in pregnancy [22]. Folate is essential for purine and thymidine nucleotide biosynthesis and homocysteine metabolism. Therefore, folate deficiency leads to DNA synthesis abnormalities, homocysteine elevation, and altered cellular gene expression [22]. Inhibited DNA synthesis affect mitosis causing ineffective erythropoiesis from hematopoietic precursor cells. Macrocytic anaemia, pancytopenia and hyper segmented neutrophils may become evident in the blood [23]. Reduction of red cell lifespan is another contributor to anaemia seen in folate deficiency [3]. The same mechanisms can lead to increased risk for congenital abnormalities (such as neural tube defects), foetal growth retardation, preterm delivery, and neonatal folate deficiency in addition to maternal anaemia [22].

Vitamin B12 deficiency is highly prevalent in some countries of the Indian subcontinent, where 32% of first trimester pregnant women are reportedly B12 deficient [24]. B12 deficiency has been reported among 15–49% of pregnant women in Latin America and the Caribbeans [25, 26]. Converting homocysteine and methyltetrahydrofolate to methionine and tetrahydrofolate requires Vitamin B12. In its deficiency, folate is trapped as methyltetrahydrofolate, causing a functional folate deficiency. Thus, pathophysiology of macrocytic anaemia and adverse foetal outcomes of B12 deficiency are similar to folate deficiency [27].

Anaemia due to hereditary conditions such as minor hemoglobinopathies or membrane disorders can be prevalent in some communities. For example, any variant of hemoglobinopathy is carried by 45.5% of the South Asian population [28]. Having a heterozygous variant haemoglobin phenotype increases the risk of anaemia in pregnancy and having a baby affected with the homozygous disease.

Successful control of anaemia in a pregnant woman requires alleviation of its aetiology. In many parts of the world, the focus of public health interventions to prevent and control anaemia in pregnancy is almost limited to controlling iron deficiency [29]. Multiple interventions across the lifecycle to build and maintain good iron stores have been adopted widely to prevent iron deficiency anaemia in pregnant women. Iron supplementation, treating anaemia with iron, deworming, and nutritional education are examples of such interventions [30].

Despite having a robust public health system catering for its population across the lifecycle, anaemia prevalence among pregnant women in Sri Lanka is 29.1% (according to routinely reported data of the reproductive health management information system (RHMIS)) [31], resembling one of the worst maternal health indicators in the country. However, many strategies have been adopted to prevent anaemia in pregnancy in the country. Early in the life cycle, iron and folate supplementation and clinical screening for anaemia are conducted at schools [32]. Universal anaemia screening with clinical and biochemical parameters is a standard component of care provided at pre conceptional clinics, first antenatal clinic visit and the clinic visit around 28 weeks of gestation. Universal folic acid supplementation is commenced pre conceptionally and continued throughout pregnancy until 6 months postpartum, coupled with iron supplementation after the first trimester of pregnancy. A food supplement, “Thriposha” (including macronutrients, iron, zinc, folic acid, vitamin B complex etc.), is provided for all pregnant and lactating women. Nutritional counselling, deworming, treating identified anaemia with double iron dose, and referral of refractory cases for further care are other interventions implemented under the country’s public health system [33, 34].

Amid the success of such strategies, other aetiologies gain prominence marking poor progress of anaemia control. Identification of aetiologies significantly contributing to anaemia in pregnancy in a particular community enables the implementation of policies and interventions to address them, leading to better control of anaemia and improved maternal and foetal outcomes. However, etiological assessment is often costly and less feasible in settings where the disease burden is highest, the LMICs. Categorising anaemia according to the red cell indices in the full blood count and using these categorisations to guide treatment and further assessment is helpful in the low resource settings.

This study aims to determine the actual prevalence of anaemia and its’ aetiologies among first trimester pregnant women in Anuradhapura district, Sri Lanka. To our knowledge, this is one of the largest studies on early maternal anaemia in LMICs and the first Sri Lankan study that assess the contribution of several important aetiologies to anaemia in pregnancy, which therefore would provide data for specific preventive strategies in vulnerable populations.


This population-based study was carried out as a part of the Rajarata Pregnancy Cohort (RaPCo) in Anuradhapura district, Sri Lanka [35]. Anuradhapura district reported a 39.1% prevalence of anaemia in pregnancy, ranking fifth-highest among the 26 health districts of the country [31]. Anaemia prevalence at the time of the first antenatal visit was 22.8%, according to RHMIS data 2018.

Pregnant women newly registered in the national pregnancy care programme from July to September 2019 were invited for the study. We selected first trimester pregnant women (up to the completion of 13 weeks of gestation) for this component. The detailed methodology has been explained elsewhere [35, 36].

We hypothesised that causes of anaemia affecting at least 10% of anaemic pregnant women would be significant from a public health point of view. To detect an aetiology with a 10% prevalence (precision 0.03, 95% confidence level, 10% nonresponse rate), at least 425 anaemic pregnant women were needed to be included. Thus, according to the anaemia prevalence in the district, at least 1866 pregnant women were needed to be recruited.

Invitation to participate in the study was sent to all eligible participants through their Public Health Midwife. From July to October 2019, a special clinic was conducted fortnightly at each health division (Medical Officer of Health area), where the eligible participants were recruited consecutively. Altogether, 226 clinics were conducted across the district for participant recruitment.

An interviewer-administered questionnaire and a physical examination to elicit clinical signs were used for data collection. In participants reporting a previously diagnosed minor hemoglobinopathy, the HPLC report was observed for verification. Venepuncture was done to collect whole blood and serum samples and to prepare peripheral blood films. All slides were prepared in the field, and the serum separation was done within 2–4 h of sample collection. Aliquots of samples were stored at -80 °C.

We performed a full blood count for all the participants. Out of the calculated minimum sample, 10% was randomly selected for Serum ferritin testing to estimate iron status [37, 38]. Peripheral blood film analysis was also performed for the subsample. In addition to that, all anaemic women in this subsample were invited to undergo B12, Folate and HPLC testing.

According to current evidence, all the anaemic women (in the original sample) were classified into five mutually exclusive categories based on their red cell indices. When there was microcytic anaemia (MCV < 80 fl) with a high RBC index (RCC ≥ 5*106_), minor hemoglobinopathy was suspected [39, 40]. They were referred to undergo High-Performance Liquid Chromatography (HPLC) [41]. When there was normocytic normochromic anaemia in a participant, a membrane disorder or mixed deficiency was suspected [42]. A peripheral blood film analysis was performed on them. B 12 or folate deficiency was suspected when there was macrocytic anaemia (MCV ≥96 fl) [43]. A peripheral blood film analysis was performed for them, and they were invited for Serum B12 and folate testing. When there was microcytic anaemia with a normal RCC, iron deficiency was suspected. When there was normocytic anaemia (MCV 80–95.9 fl) with hypochromic cells (MCH ≤27 pg), early iron deficiency was suspected [38].


Anaemia (within the first 13 weeks of gestation) was defined as having haemoglobin less than 11 g/dl [30]. Haemoglobin levels below 7 g/dl, between 7 to 9.9 g/dl and between 10 to 10.9 g/dl were used to classify severe, moderate and mild anaemia, respectively [44]. Ferritin levels equal to or below 30 ng/ml were considered as iron deficiency [38]. Serum Folate levels below 4 ng/ml and B12 less than 203 pg/ml were considered as deficiency in each nutrient [45].

Laboratory investigations

Serum ferritin, Homocysteine, B12 and Folate assessments were performed in a commercial laboratory with external quality control methods. HPLC was performed at the thalassemia unit of Teaching hospital, Anuradhapura. Other investigations (complete blood count, peripheral blood film analysis and liver functions) were performed in a public health research laboratory with internal and external quality control. Samples for serum B12, folate and homocysteine were stored and transported refrigerated and covered from exposure to sunlight. They were analysed as soon as possible with a maximum stored time of 48 h.

Data management and analysis

Data from the interviewer-administered questionnaire was entered directly into a cloud-based password secured database. Laboratory investigations data were later merged with the cloud data. The first author has manually verified a 20% of the full blood count data and all of the other laboratory investigation data used for this paper.

Data analysis was performed using SPSS version 22 and Open Epi. The graphs were prepared using GraphPad Prism and Microsoft word. Fissures exact test was performed to compare the proportions of self-reported thyroid, liver, renal and autoimmune diseases among anaemic and non-anaemic pregnant women.


Of the first trimester pregnant women registered in the public maternal care program in the district, 3127 (86% of the total population) were recruited for the anaemia study. The majority of the participants were ethnic Sinhalese (87%), and 31% were in their first pregnancy (Table 1). The mean age of the group was 28.3 years. A history of anaemia was reported by 595 (18.8%). Only 1857 (80.7%) participants reported that they were on folic acid supplementation before the pregnancy and 2977 (94.6%) were on folic acid at the time of the recruitment.

Table 1 Baseline characteristics of the 3127 first trimester pregnant women participating in the study

Haemoglobin was distributed between 7.4 to 19.6 g/dl, and the mean was 11.9 g/dl (SD 1.0). Mean MCV was 83.2 fl (SD 6.4). Mean RCC, MCH and MCHC were 4.51*106 /μl (SD-0.41), 26.6 pg (SD-2.5) and 31.88(SD-0.93), respectively.

The prevalence of anaemia in the study sample was 14.4% (95% CI 13.2–15.7, n = 451). None of them had severe anaemia (Hb < 7 g/dl), and the majority (n = 331, 10.6%) had mild anaemia. A haemoglobin level of 13 g/dl or more was observed in 399 (12.7%). The types and severity of anaemia in the sample is shown in Fig. 1.

Fig. 1
figure 1

Distribution of haemoglobin levels and the types of anaemia among 3127 first trimester pregnant women

Microcytic red cells were seen among 638 (20.4%) of the participants. The majority of anaemic women (n-243, 54%) had microcytic anaemia. Of them, 91 had RCC more than 5 * 106 /μl. This group accounted for 20.2% of the anaemic pregnant women, and their mean haemoglobin level was 10 g/dl (SE-0.1). The mean haemoglobin level in the group with microcytic anaemia and normal RCC was 9.9 g/dl (SE-0.1).

Normocytic normochromic anaemia was seen among 114 (25.3%) anaemic women. Their mean haemoglobin level was 10.6 g/dl. Normocytic hypochromic anaemia was seen in 80 (17.8%) anaemic women who had mean haemoglobin of 10.5 g/dl. Two (0.4%) of the anaemic women had macrocytic anaemia (mean haemoglobin level 9.6 g/dl). Distribution of Haemoglobin and Red cell indices; RCC, MCV, MCH, MCHC according to the type of anaemia is presented in Fig. 2.

Fig. 2
figure 2

Distribution of Haemoglobin and red cell indices according to the type of anaemia among first trimester pregnant women

Microcytic anaemia with RCC < 5 × 106 /μl

A small random subsample of 11 out of the 163 of them underwent peripheral blood film analysis. Minor hemoglobinopathy was seen in four, iron deficiency and early iron deficiency were seen in three each, and early megaloblastic changes were seen in one participant(s). HPLC reports were available in 21 (9 had records, 12 were tested during the current study), and 14 of them were confirmed as having thalassemia trait.

Normocytic normochromic anaemia

A blood film reporting was available for 89 out of 114 women with normocytic normochromic anaemia (11 blood films were of poor quality and were excluded). Four cases (4.5%, CI 1.8–11.0%) of South-East Asian Ovalocytosis were detected. It contributed to 0.9% (95% CI 0.3 to 2.3%) of anaemia in first trimester women.

Features of iron deficiency, early mixed deficiency, mixed deficiency, early megaloblastic changes and megaloblastic changes were observed in 38 (40.9%), 18 (19.4%), 6 (6.5%), 7 (7.5%) and 1 (1.1%), respectively. 19 (20.4%) blood film reports were normal. Two pregnant women, the one with megaloblastic changes and another with early megaloblastic features in their blood films, were tested for B12 and folate deficiencies. Both were confirmed as having B12 deficiency. None of them had folate deficiency.

Microcytic anaemia with high red cell count

Blood films were reported in 24 out of the 91 with microcytic anaemia and high RCC. As hypothesised, all 24 had features of minor hemoglobinopathy. Independently of them, 19 underwent HPLC as a part of this study and 17 had undergone HPLC previously. Beta Thalassemia trait was diagnosed in 35 of them while the other had Haemoglobin SE disease (HbSE). Thus, with a 100% positive predictive value observed (with 95% CI, 100–100%), we estimated that all 91 participants with microcytic anaemia and high RCC had minor hemoglobinopathies.

Anaemia with normocytic hypochromic cells

Seven randomly selected participants (out of the 84) underwent peripheral blood film analysis. Four were having changes suggestive of early iron deficiency. Two had normal blood film reporting, and one had megaloblastic changes. Independent to this, five had records of past HPLC testing, and all five were negative for minor hemoglobinopathies.

Macrocytic Anaemia

Only one out of the two cases of macrocytic anaemia had a peripheral blood film reporting. The blood film showed early megaloblastic changes. However, her serum B12 level was 321 pg/ml, and her serum folate level was 29.2 ng/ml.

Non-anaemic pregnant women

Peripheral blood film was analysed in a random sample of 143 non-anaemic women. Minor hemoglobinopathy, early iron deficiency and iron deficiency was suggested in 7 (4.9%), 12 (8.4%) and 2 (1.4%) of the blood films, respectively, and the others (122, 85.3%) did not show an abnormality.

Of the 2676 non-anaemic women, 145 had HPLC reports (136 had records, and nine underwent testing during the current study), and 12 of them were confirmed to have minor hemoglobinopathies.

Subsample analysis

213 random first trimester pregnant women from the total sample were selected for sub-sample analysis for serum ferritin. Anaemia prevalence in this sub-sample was 14.5% (n-31).

Serum ferritin

The distribution of serum ferritin was skewed to the right (skewedness 2.78). The mean and median serum ferritin level among 213 first trimester women was 67.6 (SD 55.5) and 56.8. Iron deficiency (serum ferritin < 30 ng/ml) was seen in 20.2% (n-43, CI 15.4–26.1). Serum ferritin was less than 15 ng/ml in nine (4.2%) participants. Respectively, 164 (77%) and 6 (2.8%) of participants had s. ferritin between 30 to 199.9 ng/ml and ≥ 200 ng/ml. Of those with iron deficiency, 13 (30.2%) had anaemia, while 30 (69.8%) were non-anaemic. Conversely, 41.9% of anaemic and 15.7% of and non-anaemic participants were iron deficient.

Serum ferritin level and red cell indices-based evidence on possible iron deficiency shows poor agreement (Table 2). Ferritin was low in only a quarter of women with either microcytic or hypochromic red cell indices.

Table 2 Compatibility of serum ferritin and red cell indices-based evidence of iron deficiency in early pregnancy

Serum B12 and folate

Of these 31 anaemic pregnant women, 21 came for serum vitamin B12 and folate testing. Both parameters had wide variation among the participants.

Serum Folate levels ranged between 5 and 14 ng/ml. Median, Mean and SD were 14 g/ml, 19 ng/ml and 10, respectively. Folate deficiency (< 4 ng/ml) was not observed among participants. However, one (4.8%) had a folate level below 5.9 ng/ml (risk of deficiency), and eight (38%) had high folate levels above 20 ng/ml.

Serum Vitamin B12 level of the sample varied between 154 and 721 (pg/ml). The Median was 301 pg/ml, mean was 359 pg/ml (SD178). B12 deficiency (B12 < 203 pg/ml) was observed among 5 (23.8% CI 10.6–45.1). Another five had B12 levels between 203 to 300 pg/ml, while 11 (52.4%) had B12 levels more than 300 pg/ml.

None of those with B12 deficiency had Macrocytic anaemia (according to red cell indices). However, the peripheral blood film of one of them showed oval Macrocytes. Co-existing iron deficiency was seen in two. Three of the five had high folate levels. The distribution of B12, folate and ferritin levels and types of anaemia are shown in Fig. 3.

Fig. 3
figure 3

Red cell indices, Serum Folate level, and iron and B12 deficiency status in the subsample of 21 first trimester anaemic pregnant women. (Panel a – among vitamin B12 deficient participants, panel b among participants with normal Vitamin B12 levels)

Other systemic diseases

Small percentages of anaemic pregnant women had previously diagnosed thyroid (n = 9, 2.1%), liver (n = 3, 0.7%), renal (n = 2, 0.4%), or autoimmune diseases (n = 2, 0.4%). Fissure’s exact test showed that prevalence of anaemia was not significantly different between groups with and without a diagnosed thyroid (p – 0.87), liver (p − 0.06), renal (p-1) or autoimmune disease (p-0.21).

In summary, we estimated that at least 23.3% (n = 105) of first trimester anaemic women have minor hemoglobinopathies. The prevalence of iron deficiency, B12 deficiency and Southeast Asian ovalocytosis were estimated as 41.9% (95% CI 26.4–59.2), 23.8% (CI 10.6–45.1), and 0.9 95% CI 0.3 to 2.3%) of first trimester anaemic women respectively. Folate deficiency was not observed among them.


Improving maternal health beyond numbers requires an in-depth understanding of the common conditions and incorporating those into the health systems. Public health guidelines on anaemia, a well-known underlying cause of maternal morbidity and mortality, has not been updated for many years due to a lack of understanding of underlying factors. This large population-based study examines the aetiologies of anaemia in pregnancy with a macro lens, revealing previously unidentified aspects to inform public health policy.

Using a population-based, representative sample [31, 46], including 86% of the reference population [31, 46], we demonstrated that the anaemia prevalence among first trimester pregnant women in the district was 14.4% (95% CI 13.2–15.7). This prevalence can be classified as a problem of mild public health significance [47]. Even though the reported national prevalence of anaemia in pregnancy is high (29.1%) [31], first trimester anaemia prevalence reported in studies during the last decade are consistently low (16.9 to 14.4%) [48, 49]. The absence of severe anaemia is also compatible with findings from previous studies in Sri Lanka [48, 50] showing the success of the country’s public health interventions to control anaemia across the lifecycle. Of note, a significant proportion (12.7%) had haemoglobin > 13 g/dl, a condition which has shown to be associated with adverse pregnancy outcomes [51, 52] and this needs to be followed up further.

Minor Hemoglobinopathies

Microcytic anaemia is generally associated with iron deficiency and thalassemia trait. Different red cell indices-based markers are available for minor haemoglobinopathy screening in people with microcytic anaemia. According to current evidence, the RBC index is one of the best amongst them [40]. The sensitivity and specificity of these markers vary in different populations. With the available HPLC confirmed results, we have shown that the positive predictive value of the RBC index in the study population is 100%, an observation supported by the blood film analysis as well. Combining this with already tested and confirmed cases that do not have a high RBC index, a significantly high prevalence of minor hemoglobinopathies (at least 23%) was identified among anaemic pregnant women in this population.

We did not test for alfa thalassemia in the present study, and the majority of the confirmed cases were beta-thalassemia trait. However, the global prevalence of alfa thalassemia is higher than that of beta [53]. Alfa thalassemia carrier status is estimated to be present in 20.7% of the world population [28]. A study conducted among anaemic first trimester women from a different location in Sri Lanka has also shown that the prevalence of beta-thalassemia trait was 15%, while the prevalence of alfa thalassemia trait was 17% [54]. HbE and beta-thalassemia trait were reported in 1 and 2% of school children in Anuradhapura [53]. Published data on other haemoglobin variants and the findings from the current study suggest that the contribution of minor hemoglobinopathies as an etiological factor for anaemia in pregnancy in this population is extremely higher than expected. Findings of the study (before publication) were extensively discussed among national-level policymakers. As a result, the national maternal care programme introduced a new policy to screen all anaemic pregnant women with microcytic hypochromic anaemia for minor haemoglobinopathies [55].

Iron deficiency

Serum ferritin is effective to identify iron deficiency [37]. Serum ferritin can be falsely elevated due to inflammation and should ideally be combined with an inflammatory marker such as C Reactive Protein (CRP) [37]. However, since variable ferritin cut offs are being employed to determine iron deficiency, we selected a higher cut off value of 30 ng/ml, which is the WHO recommendation for pregnant women with evidence of inflammation [37, 38]. This cut off will increase the sensitivity to detect iron deficiency despite inflammation.

Iron deficiency is well-documented among Sri Lankan pregnant women. Early studies have shown very low mean ferritin levels (12.39 ng/dl) and very high iron deficiency prevalence (69% with 12 ng/dl cut off) during pregnancy [56]. Probably due to public health interventions and improved socioeconomic status, iron deficiency has shown a decline. For example, recent hospital-based studies show that iron deficiency prevalence among pregnant women was 21.2%(Colombo, 2009) [57] and 36.9% (Mahamodara, 2015) [58]. In an island-wide sample (2015), iron deficiency varied between 10% in Anuradhapura and 42.5% in Jaffna [48]. Prevalence of iron deficiency anaemia among first trimester women was 6.4% in the hospital-based study in Colombo (13 out of 203 had ferritin < 20 ng/dl), 15.9 in a community clinic-based study in Colombo (10 out of 90 had ferritin < 30 ng/dl) and 2.4% in the national-wide sample (3 out of 127 had ferritin < 15 ng/dl) [49]. The current study presents the highest number of ferritin estimations in first trimester pregnant women of Sri Lanka, the prevalence of iron deficiency was 20.1%, and iron deficiency anaemia was 6.1%. Though Anuradhapura has a higher anaemia prevalence than most other districts, this cannot be attributed to a higher iron deficiency prevalence. Other studies from LMIC also have shown that most anaemic pregnant women are not iron deficient [59]. However, 41.9% of anaemic women have iron deficiency. Hence prevention and treatment of iron deficiency remain a priority for controlling anaemia in this community.

Even though the ferritin levels suggest a comparatively low prevalence of iron deficiency, the majority of the participants have microcytic anaemia (35.9% when high RCC is excluded) and normocytic hypochromic anaemia (18.4%). These indicators are usually attributed to iron deficiency [60]. Previous studies in this population also have shown that the Serum ferritin based iron deficiency prevalence is lower than suggested by other evidence such as red cell indices and peripheral blood film analysis [61]. This observation should be investigated further.

Vitamin B 12 and folate deficiency

Two previous studies conducted in more urban settings in Sri Lanka; among school dropped out girls (15 to 19 years old) and nonpregnant, nonlactating females (15 to 30 years old), have shown a low prevalence of B12 deficiency (1.6 and 0.44% respectively) [62, 63]. To our knowledge, this is the first study on B12 deficiency among pregnant women in Sri Lanka. Our data show that B12 deficiency is an important contributor to anaemia during early pregnancy in this population as 23.8% of anaemic first trimester women were reported to have B12 deficiency, which amounted to 2.2% of prevalence among all pregnant women. Only about 28% of B12 deficiency is manifested with haemoglobin changes [64]. We only assessed the B12 status of anaemic women. Vitamin B12 deficiency may exist without anaemia, in which case the prevalence of deficiency among pregnant women will be higher than the reported value. Poor diet could be linked to the significant prevalence of deficiency observed since vitamin B12 consumption is below the Estimated Average Requirement in 42.1% of Sri Lankans [65]. Pregnancy may lead to a 25 to 30% reduction in serum B12 levels [66]. But this change is minimum in the first trimester as the B12 level is gradually reduced to reach its lowest at term [67, 68]. Therefore, the observed B12 levels likely indicate an actual deficiency state rather than an arbitrary change due to pregnancy.

B12 deficiency during pregnancy is associated with low birth weight, preterm delivery and neural tube defects in addition to maternal anaemia [69, 70]. There is a probable Association with preeclampsia as well [70]. Further assessment of the B12 status in pregnant women in the country should be undertaken urgently and universal supplementation during pregnancy should be considered.

Folic acid deficiency has been reported among reproductive-age females of the country [62, 63]. However, we did not find anyone with folic acid deficiency, possibly because most participants had consumed Folic acid supplements during the pre-conceptional and antenatal period. It is noteworthy that a significant proportion, including 60% of the B12 deficient participants, had high folate levels. Since evidence suggests that high folic acid levels may exaggerate the effects of B12 deficiency, it is worthwhile to reconsider the strategy of supplementing high doses of folic acid (e.g., during preconception and first trimester) without B12 supplementation [27, 71].

Folate or B12 deficiency is expected to cause macrocytic anaemia [43]. Studies, including the current, show that macrocytic anaemia is uncommon among first trimester pregnant women from this region [50]. We observed megaloblastic changes (in the peripheral blood films) or low serum B12 levels in several participants with microcytic or normocytic anaemia. This observation may be attributed to the presence of mixed deficiency [72]. Therefore, using the presence of macrocytic anaemia to screen for pregnant women needing further assessment and treatment in the line of B12 or Folate deficiency is not advisable.

South-east Asian Ovalocytosis

South-East Asian Ovalocytosis has been reported from Sri Lanka previously. This is the first study reporting the significance of south-east Asian ovalocytosis in Sri Lankan pregnant women [73, 74]. One per cent of anaemic first trimester women had this condition. Cases were identified by selective screening of pregnant women with normocytic normochromic anaemia. We can attribute the anaemia in these women to the presence of membrane disorder as random testing did not find any cases among non-anaemic women.

Systemic diseases and other conditions

We did not find evidence suggesting thyroid, liver, renal or autoimmune diseases significantly contributing to maternal anaemia in this community, perhaps due to the low number of reported cases. Even though Malaria and HIV contribute to significant numbers of anaemia in pregnant women around the globe, we did not test for them in the current study as the prevalence of both conditions in Sri Lanka are negligible [75, 76].

This study has several limitations. Some aetiologies were assessed based on an evidence-based algorithm instead of a universal screening due to funding restrictions. Further, the prevalence of alfa thalassemia was not covered in this study. We established that B12 deficiency is prevalent in this community, but the sample tested was small, and studies with a larger sample are required to obtain proper estimates. Such assessments should include other micronutrient deficiencies such as vitamin B6 and Zinc as well.

The findings of this study from rural Sri Lanka calls for a re-evaluation of current universal strategies implemented in preventing anaemia in pregnancy. Even in low- and middle-income settings where iron deficiency is prominent, and the first line of management is doubling the iron dose, exploring the underlying causes of maternal anaemia will help improve mothers and babies health.


We have shown that iron deficiency remains a major cause of anaemia in pregnant women despite already implemented preventive strategies across the lifecycle. Bio-socio-cultural reasons for the continued predominance of iron deficiency in this community need to be evaluated further. Minor hemoglobinopathies significantly contribute to anaemia in pregnancy. The role of minor hemoglobinopathies in maternal anaemia in other LMIC’s needs to be further investigated. Application of sound evidence on aetiologies of anaemia in pregnancy will be beneficial in reviewing current policies and strategies in LMICs for further improvement of health in mothers and babies.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.


  1. 1.

    Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013;1:e16–25.

    PubMed  PubMed Central  Google Scholar 

  2. 2.

    Decade of Action | United Nations Development Programme. Accessed 17 Aug 2021.

  3. 3.

    Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;1450:15–31.

    PubMed  PubMed Central  Google Scholar 

  4. 4.

    Daru J, Zamora J, Fernández-Félix BM, Vogel J, Oladapo OT, Morisaki N, et al. Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: a multilevel analysis. Lancet Glob Health. 2018;6:e548–54.

    PubMed  Google Scholar 

  5. 5.

    Omotayo MO, Abioye AI, Kuyebi M, Eke AC. Prenatal anemia and postpartum hemorrhage risk: a systematic review and meta-analysis. J Obstet Gynaecol Res. 2021;47:2565–76.

    PubMed  Google Scholar 

  6. 6.

    Alwan N, Hamamy H. Maternal Iron status in pregnancy and long-term Health outcomes in the offspring. J Pediatr Genet. 2015;04:111–23.

    CAS  Google Scholar 

  7. 7.

    Brannon PM, Taylor CL. Iron supplementation during pregnancy and infancy: uncertainties and implications for research and policy. Nutrients. 2017;9.

  8. 8.

    Jwa SC, Fujiwara T, Yamanobe Y, Kozuka K, Sago H. Changes in maternal hemoglobin during pregnancy and birth outcomes. BMC Pregnancy Childbirth. 2015;15:80.

    PubMed  PubMed Central  Google Scholar 

  9. 9.

    Khoigani MG, Goli S, Hasanzadeh A. The relationship of hemoglobin and hematocrit in the first and second half of pregnancy with pregnancy outcome. Iran J Nurs Midwifery Res. 2012;17(2 Suppl 1):S165–70.

    PubMed  PubMed Central  Google Scholar 

  10. 10.

    WHO Global Database on Anaemia. Worldwide prevalence of anaemia. 1993.

    Google Scholar 

  11. 11.

    Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci. 2000:125–36.

  12. 12.

    Fisher AL, Nemeth E. Iron homeostasis during pregnancy. Am J Clin Nutr. 2017;106 Supplement 6:1567S–74S.

    Google Scholar 

  13. 13.

    Bothwell TH. Iron requirements in pregnancy and strategies to meet them. In: American Journal of Clinical Nutrition. Rockville: American Society for Nutrition; 2000.

  14. 14.

    Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. In: American Journal of Clinical Nutrition. Rockville: In, American Society for Nutrition; 2005.

  15. 15.

    Corwin EJ, Murray-Kolb LE, Beard JL. Low hemoglobin level is a risk factor for postpartum depression. J Nutr. 2003;133:4139–42.

    CAS  PubMed  Google Scholar 

  16. 16.

    Lee KA, Zaffke ME. Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. J Obstetric Gynecol Neonatal Nurs. 1999;28:183–91.

    CAS  Google Scholar 

  17. 17.

    Beard JL, Borel MJ, Derr J. Impaired thermoregulation and thyroid function in iron-deficiency anemia. Am J Clin Nutr. 1990;52:813–9.

    CAS  PubMed  Google Scholar 

  18. 18.

    Briley A, Seed P, Tydeman G, Ballard H, Waterstone M, Sandall J, et al. Reporting errors, incidence and risk factors for postpartum haemorrhage and progression to severe <scp>PPH</scp> : a prospective observational study. BJOG Int J Obstet Gynaecol. 2014;121:876–88.

    CAS  Google Scholar 

  19. 19.

    Shao J, Lou J, Rao R, Georgieff MK, Kaciroti N, Felt BT, et al. Maternal serum ferritin concentration is positively associated with newborn iron stores in women with low ferritin status in late Pregnancy1-3. J Nutr. 2012;142:2004–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Goonewardene M, Shehata M, Hamad A. Anaemia in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2012;26:3–24.

    PubMed  Google Scholar 

  21. 21.

    Darnton-Hill I, Mkparu U. Micronutrients in pregnancy in low- and middle-income countries. Nutrients. 2015;7:1744–68.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Bailey LB, Stover PJ, McNulty H, Fenech MF, Gregory JF, Mills JL, et al. Biomarkers of nutrition for development-folate review. J Nutr. 2015;145:1636S–80S.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Castellanos-Sinco HB, Ramos-Peñafiel CO, Santoyo-Sánchez A, Collazo-Jaloma J, Martínez-Murillo C, Montaño-Figueroa E, et al. Megaloblastic anaemia: folic acid and vitamin B12 metabolism. Revista Médica Del Hospital General De México. 2015;78:135–43.

    Google Scholar 

  24. 24.

    Sukumar N, Rafnsson SB, Kandala NB, Bhopal R, Yajnik CS, Saravanan P. Prevalence of Vitamin B-12 insufficiency during pregnancy and its effect on offspring birth weight: a systematic review and meta-analysis. Am J Clin Nutr. 2016;103:1232–51.

    CAS  PubMed  Google Scholar 

  25. 25.

    Brito A, Mujica-Coopman MF, López de Romaña D, Cori H, Allen LH. Folate and vitamin B12 status in Latin America and the Caribbean: an update. Food Nutr Bull. 2015;36(2 Suppl):S109–18.

    PubMed  Google Scholar 

  26. 26.

    Black AK, Allen LH, Pelto GH, De Mata MP, Chavez A. Iron, vitamin B-12 and folate status in Mexico: associated factors in men and women and during pregnancy and lactation. J Nutr. 1994;124:1179–88.

    CAS  PubMed  Google Scholar 

  27. 27.

    Allen LH, Miller JW, De Groot L, Rosenberg IH, Smith AD, Refsum H, et al. Biomarkers of nutrition for development (BOND): Vitamin B-12 review. J Nutr. 2018;148:1995S–2027S.

    PubMed  PubMed Central  Google Scholar 

  28. 28.

    WHO. Global epidemiology of haemoglobin disorders and derived service indicators. Geneva: WHO; 2011.

  29. 29.

    Buultjens M, Liamputtong P. When giving life starts to take the life out of you: women’s experiences of depression after childbirth. Midwifery. 2007;23:77–91.

    PubMed  Google Scholar 

  30. 30.

    World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: WHO Press; 2016.

  31. 31.

    Family Health Bureau Sri Lanka. Annual Report of the Family Health Bureau 2018. Colombo 10; 2020.

  32. 32.

    Office of the Director of Health Services, Ministry of Health. Weekly Iron Folate Supplementation (WIFS) for School Children. Colombo 10: Ministry of Health; 2013.

    Google Scholar 

  33. 33.

    Ministry of Health N and IM. Guidelines on De-worming Children and Pregnant Women against Soil Transmitted Helminths in Community Setting 2019–2022: Ministry of Health; 2018. p. 1–2.,Sinhala,Tamil.pdf. Accessed 12 Nov 2021

    Google Scholar 

  34. 34.

    Family Health Bureau SL. Maternal care package a guide to field healthcare workers. 2011.

    Google Scholar 

  35. 35.

    Agampodi TC, Wickramasinghe ND, Prasanna RIR, Irangani MKL, Banda JMS, Jayathilake PMB, et al. The Rajarata pregnancy cohort (RaPCo): study protocol. BMC Pregnancy Childbirth. 2020;20:374.

    PubMed  PubMed Central  Google Scholar 

  36. 36.

    Amarasinghe G, Mendis V, Agampodi T. Cross-sectional study to assess etiology and associated factors for anaemia during first trimester of pregnancy in Anuradhapura District, Sri Lanka: a protocol. F1000Research. 2021;10:223.

    Google Scholar 

  37. 37.

    World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. 2020.

    Google Scholar 

  38. 38.

    Pavord S, Daru J, Prasannan N, Robinson S, Stanworth S, Girling J. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2020;188:819–30.

    PubMed  Google Scholar 

  39. 39.

    England JM, Fraser PM. Differentiation of Iron deficiency from Thalassaemia trait by routine blood count. Lancet. 1973;301:449–52.

    Google Scholar 

  40. 40.

    Hoffmann JJML, Urrechaga E, Aguirre U. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis. Clin Chem Lab Med. 2015;53:1883–94.

    CAS  PubMed  Google Scholar 

  41. 41.

    Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013;161:639–48.

    CAS  PubMed  Google Scholar 

  42. 42.

    Schedvin G, Jones I, Hultdin J, Nilsson TK. A laboratory algorithm with homocysteine as the primary parameter reduces the cost of investigation of folate and cobalamin deficiency. Clin Chem Lab Med. 2005;43:1065–8.

    CAS  PubMed  Google Scholar 

  43. 43.

    Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166:496–513.

    CAS  PubMed  Google Scholar 

  44. 44.

    WHO Vitamin and Mineral Nutrition Information System. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011.

    Google Scholar 

  45. 45.

    Centers for Disease Control and Prevention, World Health Organization, Nutrition International U. Micronutrient survey manual. 2020.

    Google Scholar 

  46. 46.

    Department of Health- North Central Province - Maternal Health. Accessed 9 Sept 2020.

  47. 47.

    World Health Organization. The Global Prevalence of Anaemia in 2011. 2011.

    Google Scholar 

  48. 48.

    Jayatissa R, Fernando DN, De Silva H. National Nutrition and micronutrient survey of pregnant women in Sri Lanka 2015. Colombo: Medical Research Institute; 2017.

  49. 49.

    Rabindrakumar MSK, Pujitha Wickramasinghe V, Gooneratne L, Arambepola C, Senanayake H, Thoradeniya T. The role of haematological indices in predicting early iron deficiency among pregnant women in an urban area of Sri Lanka. BMC Hematol. 2018;18:37.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. 50.

    Chathurani U, Dharshika I, Galgamuwa D, Wickramasinghe N, Agampodi T, Agampodi S. Anaemia in pregnancy in the district of Anuradhapura, Sri Lanka – need for updating prevalence data and screening strategies. Ceylon Med J. 2012;57:101.

    CAS  PubMed  Google Scholar 

  51. 51.

    Dewey KG, Oaks BM. U-shaped curve for risk associated with maternal hemoglobin, iron status, or iron supplementation. In: American Journal of Clinical Nutrition. Rockville: In: Oxford University Press; 2017. p. 1694S–702S.

  52. 52.

    Ridella S. Maternal hematologic levels and pregnancy outcomes article in seminars in perinatology; 1981.

    Google Scholar 

  53. 53.

    Suresh S, Fisher C, Ayyub H, Premawardhena A, Allen A, Perera A, et al. Alpha Thalassaemia and extended alpha globin genes in Sri Lanka. Blood Cell Mol Dis. 2013;50:93–8.

    CAS  Google Scholar 

  54. 54.

    Mettananda S, Suranjan M, Fernando R, Dias T, Mettananda C, Rodrigo R, et al. Anaemia among females in child-bearing age: relative contributions, effects and interactions of α- and β-thalassaemia. Plos One. 2018;13:e0206928.

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Ministry of Health. FHB/MCU/M Anaemia/2021 - Diagnosis of anaemia and iron folate supplementation during antenatal and postnatal periods; 2021. p. 1–2. Accessed 13 Nov 2021

    Google Scholar 

  56. 56.

    Liyanage KDCE. Iron deficiency anaemia in Sri Lanka; 1992.

    Google Scholar 

  57. 57.

    Senadheera D, Goonewardene M, Mampitiya I. Anaemia and iron deficiency in pregnant women attending an antenatal clinic in a teaching hospital in southern Sri Lanka. Ceylon Med J. 2017;62:175.

    CAS  PubMed  Google Scholar 

  58. 58.

    Kaluarachchi A, Mahesh P, Jeewantha R, Wijerathne S, Goonerathne L, Goonathunge L. Study on hemoglobin levels and status of Iron Stores in Sri Lankan Pregnant Mothers in the first trimester at a tertiary care setting; 2009.

    Google Scholar 

  59. 59.

    Al-Jawaldeh A, Taktouk M, Doggui R, Abdollahi Z, Achakzai B, Aguenaou H, et al. Are countries of the eastern mediterranean region on track towards meeting the world health assembly target for anemia? A review of evidence. Int J Environ Res Public Health. 2021;18:1–26.

    Google Scholar 

  60. 60.

    Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156:588–600.

    CAS  PubMed  Google Scholar 

  61. 61.

    Amarasinghe GS, NPGCR N, Agampodi TC, Agampodi SB. Factors associated with anemia among Sri Lankan primary school children in rural North Central Province. BMC Pediatrics. 2017;17:87.

    PubMed  PubMed Central  Google Scholar 

  62. 62.

    Thoradeniya T, Wickremasinghe R, Ramanayake R, Atukorala S. Low folic acid status and its association with anaemia in urban adolescent girls and women of childbearing age in Sri Lanka. Br J Nutr. 2006;95:511–6.

    CAS  PubMed  Google Scholar 

  63. 63.

    De Lanerolle-Dias M, De Silva A, Lanerolle P, Arambepola C, Atukorala S. Micronutrient status of female adolescent school dropouts. Ceylon Med J. 2012;57:74.

    PubMed  Google Scholar 

  64. 64.

    Smith AD, Warren MJ, Refsum H. Vitamin B12. In: Advances in food and nutrition research; 2018. p. 215–79.

    Google Scholar 

  65. 65.

    Mark HE, Houghton LA, Gibson RS, Monterrosa E. Estimating dietary micronutrient supply and the prevalence of inadequate intakes from national Food Balance Sheets in the South Asia region. Asia Pac J Clin Nutr. 2016;25(February 2015):368–76.

    CAS  PubMed  Google Scholar 

  66. 66.

    Sobczyn A, Harrington DJ. Laboratory assessment of folate (Vitamin B9) status. J Clin Pathol. 2018;71:949–56.

    Google Scholar 

  67. 67.

    Boger WP, Wright LD, Beck GD, Bayne GM. Vit. B12: Correlation of Serum Concentrations and Pregnancy. Proc Soc Exp Biol Med. 1956;92:140–3.

    CAS  PubMed  Google Scholar 

  68. 68.

    Metz J, McGrath K, Bennett M, Hyland K, Bottiglieri T. Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal serum vitamin B12 levels. Am J Hematol. 1995;48:251–5.

    CAS  PubMed  Google Scholar 

  69. 69.

    Rogne T, Tielemans MJ, Chong MFF, Yajnik CS, Krishnaveni GV, Poston L, et al. Associations of maternal Vitamin B12 concentration in pregnancy with the risks of preterm birth and low birth weight: a systematic review and Meta-analysis of individual participant data. Am J Epidemiol. 2017;185:212–23.

    PubMed  Google Scholar 

  70. 70.

    Mardali F, Fatahi S, Alinaghizadeh M, Kord Varkaneh H, Sohouli MH, Shidfar F, et al. Association between abnormal maternal serum levels of vitamin B12 and preeclampsia: a systematic review and meta-analysis. Nutr Rev. 2020.

  71. 71.

    Lai JS, Pang WW, Cai S, Lee YS, Chan JKY, Shek LPC, et al. High folate and low vitamin B12 status during pregnancy is associated with gestational diabetes mellitus. Clin Nutr. 2018;37:940–7.

    CAS  PubMed  Google Scholar 

  72. 72.

    Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008;112:2214–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. 73.

    Gunaratne W, Dissanayake D, Jayaratne K, Premawardhana NP, Siribaddana S. A case series of distal renal tubular acidosis, Southeast Asian ovalocytosis and metabolic bone disease. BMC Nephrol. 2020;21:327.

    CAS  PubMed  PubMed Central  Google Scholar 

  74. 74.

    Vidyatilake H, Gooneratne L. Two families in Sri Lanka with southeast Asian ovalocytosis. Ceylon Med J. 2011;49:27.

    Google Scholar 

  75. 75.

    World Bank. HIV/AIDS in Sri Lanka. Accessed 18 Dec 2016.

  76. 76.

    Case Management - Anti Malaria Campaign | Sri Lanka. Accessed 1 Apr 2021.

Download references


We would like to acknowledge the Provincial and district level health personnel who supported the establishment of RaPCo; Dr. Palitha Bandara (Provincial director of Health Services North Central Province), Dr. N.C.D Ariyarathne (Regional Director of Health Services Anuradhapura district), Medical Officers of Health, Additional Medical Officers of Health and staff members of MOH offices in Anuradhapura district. We also acknowledge the kind support offered by Dr. W.H.E Alwis (Haematologist, Teaching Hospital Anuradhapura), Thalassemia Unit Anuradhapura for facilitating laboratory investigations in the study.


This work was supported by the Accelerating Higher Education Expansion and Development (AHEAD) Operation of the Ministry of Higher Education, Sri Lanka funded by the World Bank (DOR STEM HEMS [6026-LK/ 8743-LK]). Part of the investigations was financially supported by the Deans award for publication, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka. The funding body had no role in the design of the study and collection, analysis, or interpretation of data and in writing the manuscript.

Author information




GSA involved in formulating the research question, designing the study, carrying out the study, analysing the data, interpreting the findings and writing the article. TCA involved in formulating the research question, designing the study and supervision of carrying out the study, analysing the data, interpreting the findings and writing the article. VM involved in designing the study, carrying out the study, and supervision of analysing the data, interpreting the findings and writing the article. KM involved in formulating the research question, designing the study and carrying out the study. CK involved in designing the study and data collection; SBA involved in involved formulating the research question, designing the study and supervision of carrying out the study, analysing the data, interpreting the findings and writing the article. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Gayani Shashikala Amarasinghe.

Ethics declarations

Ethics approval and consent to participate

Informed written consent was obtained from all the participants. The study was approved by the Ethics Review Committee of Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka (ERC/2019/07). All the work was conducted per the guidelines laid down by the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Amarasinghe, G.S., Agampodi, T.C., Mendis, V. et al. Prevalence and aetiologies of anaemia among first trimester pregnant women in Sri Lanka; the need for revisiting the current control strategies. BMC Pregnancy Childbirth 22, 16 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Anaemia
  • Pregnancy
  • Iron deficiency
  • Vitamin B12
  • Folate
  • South-east Asian Ovalocytosis
  • Sri Lanka